SCHEMBL30890576

SCHEMBL30890576

CCCCOC(=O)N1CC2(CC1C(=O)O)OCc1ccccc1NC2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OTUD7B Q6GQQ9 1/20 0.41
▸ TSHR P16473 2/20 0.34
▸ OPRL1 P41146 1/20 0.33
▸ BCHE P06276 1/20 0.33
▸ L3MBTL1 Q9Y468 3/20 0.33
▸ ECE1 P42892 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ ACE P12821 2/20 0.33
▸ ACE2 Q9BYF1 2/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ G6PD P11413 1/20 0.31
▸ OPRD1 P41143 1/20 0.30
▸ OPRK1 P41145 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890510 0.92 OTUD7B (0.40) OTUD7BTSHROPRL1BCHEL3MBTL1
SCHEMBL30890444 0.86 POLB (0.36) TSHRBCHEL3MBTL1ECE1KDM4E
SCHEMBL30890404 0.86 POLB (0.36) TSHRBCHEL3MBTL1ECE1KDM4E
SCHEMBL30890412 0.78 HSD17B10 (0.36) TSHRBCHEL3MBTL1ECE1KDM4E
SCHEMBL30890741 0.75 RECQL (0.34) TSHRMAPK1TDP1MAPTOPRD1
SCHEMBL30992215 0.74 OTUD7B (0.42) OTUD7BMAPK1
SCHEMBL30890474 0.73 TSHR (0.32) TSHRMEN1KMT2A
SCHEMBL17294841 0.73 BCHE (0.40) TSHRBCHEL3MBTL1ECE1KDM4E
SCHEMBL30890571 0.70 MAPT (0.34) L3MBTL1MEN1KMT2AMAPT
SCHEMBL30890780 0.70 MAOB (0.34) TSHRKDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback